financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Molson Coors Brewing Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Strong Buy Opinion On Shares Of Molson Coors Brewing Company
Apr 30, 2024 5:29 AM

08:05 AM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We maintain a 12-month target of $75, based on a '25 P/E of 12.3x, a discount to TAP's 10-year mean forward P/E of 16.0x. We raise our adjusted EPS estimates to $6.00 from $5.70 for '24 and to $6.10 from $5.75 for '25. TAP posts Q1 adjusted EPS of $0.95 vs. $0.54 (+76%), well ahead of the $0.75 consensus. The beat was driven by stronger-than-expected sales and margins, as net sales rose 10.7% to $2.60B ($90M ahead of consensus), on improved price/sales mix (+4.4%) and higher financial volumes (+5.7%). Gross margin expanded 430 bps to 37.1% (150 bps above consensus). TAP maintained prior 2024 guidance, but we believe the forecast is likely to prove conservative following the strong Q1 results. TAP also repurchased 1.76M shares for $111M during Q1. We think TAP's results should alleviate concerns about more difficult comps, as its North American market share gains annualize. TAP's recent de-leveraging is notable, as its net debt/TTM EBITDA ratio fell to 2.3x at the end of Q1 versus 3.0x one year earlier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Adss Of Sanofi
Research Alert: CFRA Keeps Buy Opinion On Adss Of Sanofi
Jul 31, 2025
01:35 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target price to USD57 from USD65, which implies a 2025 P/E of 12.8x. This is in line with peer average and above its five-year historical forward P/E...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Gsk
Aug 1, 2025
07:05 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price to USD40 (USD43), implying 9x our 2025 EPADS estimate, implying a 2025 P/E of 9x, which is largely in line with its three-year historical forward...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Illinois Tool Works Inc.
Research Alert: CFRA Keeps Sell Opinion On Shares Of Illinois Tool Works Inc.
Jul 31, 2025
01:50 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target to $225 (from $220) following ITW's Q2 print, valuing shares at 20x our 2026 EPS estimate of $11.25 (up from $11.02; 2025 EPS outlook raised...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Ing Group
Research Alert: CFRA Keeps Hold Opinion On Adss Of Ing Group
Jul 31, 2025
12:50 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to USD25 from USD22, reflecting consensus 2025 P/B of 1.31x. The implied premium to its five-year historical average P/B of 0.84x is justified in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved